Indoco Remedies Limited (INDOCO.NS)
INR 337.35
(-0.41%)
INR 337.35
(-0.41%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 6.71 Billion INR | 101.88% |
| 2022 | 3.32 Billion INR | 29.68% |
| 2021 | 2.56 Billion INR | -3.78% |
| 2020 | 2.66 Billion INR | -0.77% |
| 2019 | 2.68 Billion INR | -9.64% |
| 2018 | 2.97 Billion INR | 5.34% |
| 2017 | 2.82 Billion INR | 12.67% |
| 2016 | 2.5 Billion INR | 97.09% |
| 2015 | 1.27 Billion INR | 44.15% |
| 2014 | 882.3 Million INR | 22.96% |
| 2013 | 717.53 Million INR | -39.4% |
| 2012 | 1.18 Billion INR | 34.19% |
| 2011 | 882.37 Million INR | -11.71% |
| 2010 | 999.35 Million INR | 51.33% |
| 2009 | 660.39 Million INR | 18.88% |
| 2008 | 555.53 Million INR | 0.0% |
| 2006 | 355.52 Million INR | -1.95% |
| 2005 | 362.59 Million INR | -27.12% |
| 2004 | 497.55 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 8.18 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 6.71 Billion INR | 101.88% |
| 2023 Q2 | 4.96 Billion INR | 0.0% |
| 2023 Q4 | 6.71 Billion INR | 0.0% |
| 2022 Q4 | 3.32 Billion INR | 0.0% |
| 2022 FY | 3.32 Billion INR | 29.68% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 2.98 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 2.56 Billion INR | -3.78% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 2.56 Billion INR | 0.0% |
| 2021 Q2 | 2.63 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 2.09 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 2.66 Billion INR | 0.0% |
| 2020 FY | 2.66 Billion INR | -0.77% |
| 2019 FY | 2.68 Billion INR | -9.64% |
| 2019 Q4 | 2.68 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 2.14 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q1 | - INR | 0.0% |
| 2018 FY | 2.97 Billion INR | 5.34% |
| 2018 Q4 | 2.97 Billion INR | 0.0% |
| 2017 FY | 2.82 Billion INR | 12.67% |
| 2016 FY | 2.5 Billion INR | 97.09% |
| 2015 FY | 1.27 Billion INR | 44.15% |
| 2014 FY | 882.3 Million INR | 22.96% |
| 2013 FY | 717.53 Million INR | -39.4% |
| 2012 FY | 1.18 Billion INR | 34.19% |
| 2012 Q4 | 1.2 Billion INR | 0.0% |
| 2012 Q3 | - INR | 0.0% |
| 2011 FY | 882.37 Million INR | -11.71% |
| 2010 FY | 999.35 Million INR | 51.33% |
| 2009 FY | 660.39 Million INR | 18.88% |
| 2008 FY | 555.53 Million INR | 0.0% |
| 2006 FY | 355.52 Million INR | -1.95% |
| 2005 FY | 362.59 Million INR | -27.12% |
| 2004 FY | 497.55 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | -369.732% |
| Ind-Swift Limited | 10.13 Billion INR | 33.731% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -101.896% |
| Sakar Healthcare Limited | 793.51 Million INR | -746.813% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 89.892% |
| Innova Captab Limited | 2.45 Billion INR | -174.153% |
| Divi's Laboratories Limited | 30 Million INR | -22298.667% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -14513.544% |
| Morepen Laboratories Limited | 289.99 Million INR | -2217.167% |
| Mankind Pharma Limited | 2.07 Billion INR | -224.348% |
| Sequent Scientific Limited | 4.87 Billion INR | -37.783% |
| Wanbury Limited | 1.16 Billion INR | -476.866% |
| Laurus Labs Limited | 25.77 Billion INR | 73.929% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -5.731% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -3818.591% |
| Alembic Limited | 91.5 Million INR | -7243.825% |
| Hikal Limited | 8.17 Billion INR | 17.811% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -30.946% |
| Neuland Laboratories Limited | 953.89 Million INR | -604.437% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -77.927% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 45.41% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -1951.16% |
| Themis Medicare Limited | 957.92 Million INR | -601.477% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 16.444% |
| Lupin Limited | 29.21 Billion INR | 77.002% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -38779.824% |
| Wockhardt Limited | 23.56 Billion INR | 71.479% |
| Vaishali Pharma Limited | 134.91 Million INR | -4880.507% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -135.569% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -7415.49% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 81.66% |
| FDC Limited | 205.18 Million INR | -3174.898% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 66.436% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -2023.331% |
| Eris Lifesciences Limited | 27.81 Billion INR | 75.84% |
| Venus Remedies Limited | 413.3 Million INR | -1525.841% |
| ZIM Laboratories Limited | 1.08 Billion INR | -517.472% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -573.036% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -34009.645% |
| Shilpa Medicare Limited | 9.37 Billion INR | 28.316% |
| Albert David Limited | 33.24 Million INR | -20114.187% |
| Ajanta Pharma Limited | 352.8 Million INR | -1804.649% |
| Hester Biosciences Limited | 2.44 Billion INR | -174.967% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -933.842% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 33.568% |
| Gufic Biosciences Limited | 3.32 Billion INR | -101.841% |
| Windlas Biotech Limited | 36.41 Million INR | -18355.369% |
| Procter & Gamble Health Limited | 95.6 Million INR | -6928.87% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -2043.255% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -582.245% |
| Granules India Limited | 13.15 Billion INR | 48.903% |
| Aarti Drugs Limited | 5.64 Billion INR | -19.085% |
| Bal Pharma Limited | 1.39 Billion INR | -381.18% |
| Alkem Laboratories Limited | 14.18 Billion INR | 52.626% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 79.474% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -62888.376% |
| Medicamen Biotech Limited | 308.17 Million INR | -2080.471% |
| Unichem Laboratories Limited | 2.47 Billion INR | -171.483% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -2655.143% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -153000.934% |
| Valiant Laboratories Limited | 767.08 Million INR | -775.993% |
| Orchid Pharma Limited | 1.35 Billion INR | -397.083% |
| Medico Remedies Limited | 80.5 Million INR | -8246.914% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -3942.691% |
| Ipca Laboratories Limited | 14.38 Billion INR | 53.283% |
| Brooks Laboratories Limited | 56.41 Million INR | -11810.172% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -827.013% |
| Piramal Enterprises Limited | 535.85 Billion INR | 98.746% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 83.293% |
| NATCO Pharma Limited | 3.71 Billion INR | -81.024% |
| Suven Life Sciences Limited | 7.09 Million INR | -94582.26% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -247.393% |
| Strides Pharma Science Limited | 25.16 Billion INR | 73.302% |
| Alpa Laboratories Limited | 52.46 Million INR | -12707.777% |
| Lasa Supergenerics Limited | 220.76 Million INR | -2943.821% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -998.872% |